Sanofi signs US rights deal with Roche for flu treatment Tamiflu
23 Jul 2019
A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France. File photo/Reuters
French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the ‘Tamiflu’ product in the United States.
The deal will give Sanofi exclusive US over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu.
“This is a strategic and important transaction for us as we strive to continually bring innovations to the market,” said Alan Main, executive vice president of Sanofi’s consumer healthcare division, in a statement.